{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:39:56Z","timestamp":1787744396615,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100032198","name":"Bangabandhu Sheikh Mujib Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000991","name":"Monash University Faculty of Medicine Nursing and Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000991","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.pathol.2025.04.003","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T19:10:07Z","timestamp":1749237007000},"page":"917-924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The diagnostic utility of the captopril challenge test for primary aldosteronism in a Bangladeshi population: a prospective study"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9021-9409","authenticated-orcid":false,"given":"Sharmin","family":"Jahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong X.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1073-3614","authenticated-orcid":false,"given":"Muhammad","family":"Akram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Hasanat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fariduddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-4976","authenticated-orcid":false,"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.pathol.2025.04.003_bib1","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.pathol.2025.04.003_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.pathol.2025.04.003_bib3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5694\/mja2.51438","article-title":"Detecting primary aldosteronism in Australian primary care: a prospective study","volume":"216","author":"Libianto","year":"2022","journal-title":"Med J Aust"},{"key":"10.1016\/j.pathol.2025.04.003_bib4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pathol.2025.04.003_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.pathol.2025.04.003_bib6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.pathol.2025.04.003_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11886-019-1185-x","article-title":"Primary aldosteronism: cardiovascular outcomes pre-and post-treatment","volume":"21","author":"Hundemer","year":"2019","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"10.1016\/j.pathol.2025.04.003_bib8","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-22-0249","article-title":"Mineralocorticoid receptor signalling in primary aldosteronism","volume":"259","author":"Yang","year":"2023","journal-title":"J Endocrinol"},{"issue":"1","key":"10.1016\/j.pathol.2025.04.003_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ejendo\/lvac002","article-title":"International multicenter survey on screening and confirmatory testing in primary aldosteronism","volume":"188","author":"Naruse","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.pathol.2025.04.003_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12020-022-03084-x","article-title":"Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care","volume":"77","author":"Ariens","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.pathol.2025.04.003_bib11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0025-6196(11)62105-8","article-title":"Validity of the aldosterone-renin ratio used to screen for primary aldosteronism","volume":"76","author":"Montori","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pathol.2025.04.003_bib12","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2025.04.003_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tem.2008.01.005","article-title":"Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis","volume":"19","author":"Giacchetti","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pathol.2025.04.003_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tem.2005.02.007","article-title":"Diagnosis of primary aldosteronism: from screening to subtype differentiation","volume":"16","author":"Mulatero","year":"2005","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.pathol.2025.04.003_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101368","article-title":"Primary aldosteronism: treatment of the disease, and new therapeutic approaches","volume":"34","author":"Funder","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2025.04.003_bib16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/s-0029-1246186","article-title":"Confirmatory tests in the diagnosis of primary aldosteronism","volume":"29","author":"Mulatero","year":"2010","journal-title":"Horm Metab Res"},{"issue":"11","key":"10.1016\/j.pathol.2025.04.003_bib17","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1210\/jc.2018-01394","article-title":"Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism","volume":"103","author":"Stowasser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.pathol.2025.04.003_bib18","doi-asserted-by":"crossref","DOI":"10.1530\/EC-23-0445","article-title":"Captopril challenge test: an underutilized test in the diagnosis of primary aldosteronism","volume":"13","author":"Jahan","year":"2024","journal-title":"Endocr Connect"},{"issue":"4","key":"10.1016\/j.pathol.2025.04.003_bib19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.eprac.2020.10.016","article-title":"Seated saline suppression test is comparable with captopril challenge test for the diagnosis","volume":"27","author":"Liu","year":"2021","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.pathol.2025.04.003_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory tests for the diagnosis of primary Aldosteronism: a prospective diagnostic accuracy study","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.pathol.2025.04.003_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.31128\/AJGP-07-19-4995","article-title":"Screening for primary aldosteronism: how to adjust existing antihypertensive medications to avoid diagnostic errors","volume":"49","author":"Gurgenci","year":"2020","journal-title":"Aust J Gen Pract"},{"issue":"3","key":"10.1016\/j.pathol.2025.04.003_bib22","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz150","article-title":"Diagnosis of primary aldosteronism by seated saline suppression test-variability between immunoassay and HPLC-MS\/MS","volume":"105","author":"Thuzar","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2025.04.003_bib23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J"},{"issue":"6","key":"10.1016\/j.pathol.2025.04.003_bib24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/s-0029-1246186","article-title":"Confirmatory tests in the diagnosis of primary aldosteronism","volume":"42","author":"Mulatero","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pathol.2025.04.003_bib25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/jcem-57-5-892","article-title":"Single dose captopril as a diagnostic test for primary aldosteronism","volume":"57","author":"Lyons","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.pathol.2025.04.003_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1210\/jc.2015-2840","article-title":"Sodium infusion test for diagnosis of primary Aldosteronism in Chinese population","volume":"101","author":"Li","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.pathol.2025.04.003_bib27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1210\/jc.2017-01530","article-title":"Evaluation of the saline infusion test and the captopril challenge test in Chinese patients with primary aldosteronism","volume":"103","author":"Meng","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.pathol.2025.04.003_bib28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","article-title":"Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma","volume":"50","author":"Rossi","year":"2007","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.pathol.2025.04.003_bib29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1507\/endocrj.EJ19-0498","article-title":"Parameters of captopril challenge test can predict results of other confirmatory tests for primary aldosteronism and propose the next test to be done","volume":"67","author":"Tamura","year":"2020","journal-title":"Endocr J"},{"key":"10.1016\/j.pathol.2025.04.003_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3803\/EnM.2016.31.2.277","article-title":"Diagnostic role of captopril challenge test in Korean subjects with high aldosterone-to-renin ratios","volume":"31","author":"Kim","year":"2016","journal-title":"Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.pathol.2025.04.003_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/cen.14134","article-title":"Chongqing Primary Aldosteronism Study (CONPASS) group. A combination of captopril challenge test after saline infusion test improves diagnostic accuracy for primary aldosteronism","volume":"92","author":"Lin","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"10.1016\/j.pathol.2025.04.003_bib32","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.pathol.2025.04.003_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchy.2020.100029","article-title":"The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism","volume":"5","author":"Rossi","year":"2020","journal-title":"Int J Cardiol Hypertens"},{"issue":"3","key":"10.1016\/j.pathol.2025.04.003_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.CIR.101.3.329","article-title":"Essential hypertension. Part I: definition and etiology","volume":"101","author":"Carretero","year":"2000","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pathol.2025.04.003_bib35","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1210\/jc.2010-2918","article-title":"Effect of contraceptives on aldosterone\/renin ratio may vary according to the components of the contraceptive, renin assay method, and possibly route of administration","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.pathol.2025.04.003_bib36","article-title":"Captopril challenge test in the diagnosis of primary aldosteronism: consistency between 1- and 2- h sampling","volume":"14","author":"Liu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302525001801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302525001801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T08:32:04Z","timestamp":1763713924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302525001801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0031302525001801"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2025.04.003","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diagnostic utility of the captopril challenge test for primary aldosteronism in a Bangladeshi population: a prospective study","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2025.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}